Background-To define and evaluate coronary contrast opacification gradients using prospectively ECG-gated single heart beat 320-detector row coronary angiography (CTA). Methods and Results-Thirty-six patients with normal coronary arteries determined by 320ϫ0.5-mm detector row coronary CTA were retrospectively evaluated with customized image postprocessing software to measure Hounsfield Units at 1-mm intervals orthogonal to the artery center line. Linear regression determined correlation between mean Hounsfield Units and distance from the coronary ostium (regression slope defined as the distance gradient G d ), lumen cross-sectional area (G a ), and lumen short-axis diameter (G s ). For each gradient, differences between the 3 coronary arteries were analyzed with ANOVA. Linear regression determined correlations between measured gradients, heart rate, body mass index, and cardiac phase. To determine feasibility in lesions, all 3 gradients were evaluated in 22 consecutive patients with left anterior descending artery lesions Ն50% stenosis. For all 3 coronary arteries in all patients, the gradients G a and G s were significantly different from zero (PϽ0.0001), highly linear (Pearson r values, 0.77 to 0.84), and had no significant difference between the left anterior descending, left circumflex, and right coronary arteries (PϾ0.503). The distance gradient G d demonstrated nonlinearities in a small number of vessels and was significantly smaller in the right coronary artery when compared with the left coronary system (PϽ0.001). Gradient variations between cardiac phases, heart rates, body mass index, and readers were low. Gradients in patients with lesions were significantly different (PϽ0.021) than in patients considered normal by CTA. Conclusions-Measurement of contrast opacification gradients from temporally uniform coronary CTA demonstrates feasibility and reproducibility in patients with normal coronary arteries. For all patients, the gradients defined with respect to the coronary lumen cross-sectional area and short-axis diameters are highly linear, not significantly influenced by the coronary artery (left anterior descending artery versus left circumflex versus right coronary artery), and have only small variation with respect to patient parameters. Preliminary evaluation of gradients across coronary artery lesions is promising but requires additional study. (Circ Cardiovasc Imaging. 2010;3:179-186.)
T he number and width of CT detector rows determine the craniocaudal coverage per gantry rotation. Coronary CT angiography (CTA) with 64 detector rows, each 0.5 mm wide, simultaneously records 32 mm (64ϫ0.5 mm) of image data per gantry rotation. Thus, multiple gantry rotations are combined for image interpretation; each rotation contributes a cardiac subvolume. Spatial misalignment between subvolumes is termed stair-step or slab artifact. Temporal misalignment between subvolumes for coronary contrast opacification refers to differences in attenuation induced by time differ-ences between acquisitions of the superior versus inferior subvolumes.
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Wide area detector CT provides up to 160-mm (320ϫ0.5 mm detector rows) craniocaudal coverage, eliminating spatial and temporal misalignment in coronary CTA. Whole volume acquisition enables quantification of the spatial variation in Hounsfield units (HU) over the entire coronary at a single point in time. We define the term "coronary contrast opacification gradient" to describe these changes. If these parameters could be rapidly and reproducibly computed, they would have the potential to extend the role of cardiac CT beyond coronary artery morphology alone. One advantage could be realized in patients with diffuse coronary artery disease (CAD) where the lumen area is diffusely smaller than normal 1, 2 and thus there is no normal reference segment for quantitative measures. Moreover, lesions with Ͻ50% narrowing in these patients are considered a substrate for plaque rupture and acute coronary syndrome. [3] [4] [5] An initial experiment of normal coronary arteries imaged by CT in a single R-R measured the difference of the mean HU between the ostium and the point where the normal vessel tapered to 2.5-mm diameter. This work showed a small but consistent decrease in contrast opacification from the proximal to distal coronary artery. 6 This project extends the quantitative assessment of normal coronary contrast attenuation by sampling coronary HU every 1 mm along the artery. This high rate of sampling enables evaluation of opacification gradients as opposed to difference measurements. Although coronary segmentation is available for several postprocessing software packages, customized software is required to extract the mean HU orthogonal to the center line at 1-mm intervals. Using a customized software package developed for coronary contrast opacification gradients, the primary purpose of this study was to demonstrate that 3 opacification gradients can be noninvasively measured using single heart beat 320-detector row CT in patients with normal arteries. The first gradient, the "distance gradient" (denoted G d ), is defined as the change in HU per centimeter of coronary artery. The second and third gradients are defined as the change in HU with respect to the coronary artery lumen area (G a ) and short-axis diameter (G s ) orthogonal to the center line, respectively. The second purpose of this study was to evaluate the properties of the 3 gradients, including goodness-of-fit of the respective linear model, potential differences between the three main coronary arteries, and the influence of patient heart rate (HR) and body mass index (BMI).
Methods

Patients
The institutional human research committee approved this retrospective study and waived the need for written informed consent. All patients had clinical indications for coronary CTA. We retrospectively evaluated 36 consecutive single R-R 320ϫ0.5 mm detector configuration (Toshiba AquilionOne Dynamic Volume CT, Tochigiken, Japan) prospectively ECG-gated coronary CTA patients with normal coronary arteries ( Table 1 ). The diagnosis of normal coronary arteries was obtained from the CT imaging reports at our institution. The phase window included 25% (60% to 85%) of the R-R interval; this protocol has an estimated radiation dose of 5 to 6 mSv, depending on body habitus. Two patients were used to study cardiac phase variation. One was in the 36-patient cohort described above. The second was an additional patient with no CT evidence of CAD but who underwent retrospective ECG gating without tube current modulation. Twenty-five consecutive patients with Ն50% stenosis in the left anterior descending coronary artery (LAD) were used to test feasibility of computing gradients from prospectively ECG gated single R-R coronary CTA ( Table 1) . Three of these patients were excluded because of errors in coronary segmentation: 2 from dense calcification and 1 from a coronary stent. Of the remaining 22 patients included in the study, all 7 who underwent conventional coronary angiography had confirmation of the LAD disease.
Three hundred twenty detector-row CT images were acquired with 350-ms gantry rotation time and 120 kV tube voltage. Among the total 58 patients, 43 were acquired at 400 mA (standard); 15 patients were imaged at 580 mA because of a large body habitus. All patients received 80 mL iopamidol 370 mg I/mL (Isovue-370, Bracco Diagnostics, Princeton, NJ) and 40 mL saline, both at 6 mL/s, injected with a dual injector (EZEM Empower CTA DUAL Injector, EZEM Inc, Lake Success, NY). Bolus tracking in the descending aorta was performed using a 200-HU threshold.
The target HR for ␤-blockade (intravenous metoprolol, 5-mg increments to a maximum of 20 mg) was 65 beats per minute. There were no patients with contraindication to ␤-blockade, and there were no observed or reported side effects from the ␤-blockers. All 58 patients received 0.4 mg sublingual nitroglycerine before imaging. 
Coronary Vessel Segmentation
For each patient, at least 1 phase was identified to have excellent image quality for the LAD, left circumflex artery (LCx), and right coronary artery (RCA). DICOM images from this phase were reformatted with a customized plug-in for OsiriX 3.0.2, based on a 3D "virtual contrast injection" method. 7 The following data were obtained from the region of interest defined as the entire segmented lumen at every millimeter orthogonal to the coronary center line beginning at the ostium and ending where each vessel had adequate segmentation, typically when the diameter tapered to roughly 1.5 mm: the mean and maximum attenuation (in HU), the crosssectional area (in millimeters squared), and the shortest diameter of the cross-section or the "short axis" (in millimeters). For each vessel, a cardiovascular imager with 6 years of experience manually determined the distal point and corrected the lumen regions of interest generated by the vessel segmentation software when required, for example at branch points.
Definition of Coronary Opacification Gradients
The 3 opacification gradients were computed using linear regression from the segmented data. The distance gradient, denoted G d , has units of HU per centimeter of coronary artery and is defined as the slope of the regression model, measured HUϭlocationϫG d ϩc, where the "location" is the distance distal to ostium in centimeters, and c is a constant determined from the linear regression. Note that G d is inherently less than zero because HU measurements decrease distally in a normal coronary artery imaged with 320-detector row CT. 6 The area gradient, denoted G a , has units of HU per millimeter squared and is defined as the measured HUϭareaϫG a ϩc, where "area" refers to the cross-sectional lumen area orthogonal to the center line. The short-axis diameter gradient, denoted G s , has units of HU per millimeter and is defined as measured HUϭshort-axis diameterϫG s ϩc. As with the distance gradient, the slopes and constants for the linear equations representing the cross-sectional area and short-axis diameter gradients were obtained using linear regression. Coronary opacification gradients for normal patients were computed for both the mean and maximum HU values from the vessel segmentation. Detailed analyses of contrast opacification uses the mean HU over the entire lumen. The maximum HU gradients were used for validation in normal vessels; for normal arteries, the maximum HU gives an assessment relatively independent of partial volume effects.
Statistical Analyses
For regression models, the Pearson correlation coefficient (r) was used to determine the strength of correlation, that is, the goodnessof-fit. A magnitude of rՅ0.25 indicates low correlation, 0.25Ͻ rՅ0.5 moderate, 0.5ϽrՅ0.75 strong, and rϾ0.75 excellent. We considered PϽ0.05 (2-sided t test) to define a regression coefficient (slope) significantly different from zero.
General Properties of Gradients
The Pearson correlation coefficient and corresponding probability value were used to determine whether the gradient models defined were appropriate for each normal coronary artery, that is, if the correlation was at least moderate (rϾ0.25) and the corresponding gradient (slope) was nonzero (PϽ0.05). Only gradients meeting these criteria were further evaluated. Gradients in patients with no CT evidence of CAD underwent 1-way ANOVA to test the hypothesis that there is no significant difference of the mean gradient between the 3 major coronary arteries (LAD, LCx, and RCA).
Agreement between gradients determined from the mean versus maximum HU measurements in normal vessels was assessed using the Pearson correlation coefficient (r).
Variability and Reproducibility of Measured Gradients
HR and BMI
For the 36 normal patients, linear regression models were used to determine whether each of the 3 gradients was correlated to patient HR and BMI for each vessel. The regression coefficients were used to estimate the influence of HR variations between 55 and 65 beats per minute and patients with a BMI between 20 and 30 kg/m 2 .
Drift Over Cardiac Phases
Linear regression models were used to evaluate for drift (ie, a statistically significant trend) in gradient magnitude during the cardiac cycle for the LAD in the patient who underwent retrospective ECG gating (5% to 95%) plus 1 of the 36 normal patients for whom segmentation was performed in all 3 arteries at all 1% intervals between 60% to 85%.
Interobserver Agreement
In the patient for whom segmentation was performed at all 1% intervals between 60% to 85%, a second cardiovascular imager independently segmented and corrected all 3 arteries at 9 phases (3% intervals). Interobserver agreement was assessed using the Pearson correlation coefficient between gradient magnitudes resulting from the individual segmentations.
Preliminary Evaluation of Gradients in Patients With CAD
For the CAD cohort, all 22 patients had Ն50% LAD stenosis as determined by CT. Gradients in the LAD were computed using the same method as patients with normal coronary arteries. A 2-sided t test was used to assess whether each of the 3 gradients was the same in vessels without versus in vessels with lesions. In this case, PϽ0.05 indicated that the mean gradient was significantly different between the 2 groups of patients.
Phantom Experiment to Determine Potential HU Changes Over the Coronary Artery Field of View
To assess potential attenuation drift inherent to the CT scanner, HU differences were evaluated via a Delrin cylinder phantom (TOS phantom, Toshiba Medical Systems Corporation, Otawara, Japan), chosen because the properties (330 HU, densityϭ1.42 g/cm 3 ) roughly match a normal contrast enhanced coronary lumen. The phantom was scanned with one 0.5-second axial 320ϫ0.5 mm detector row gantry rotation, 120 kV, 300 mA rotation, and 5-mm reconstruction thickness. The Delrin CT number was measured via placement of a 330 mm 2 circular region of interest every 5 mm over the central 13 cm of the gantry, corresponding to the location of the coronary arteries from which the 3 gradients are computed.
Results
General Properties of Gradients
The cross-sectional area (G a ) and short-axis diameter (G s ) opacification gradients ( Figure 1 ) are significantly different from zero (Pϭ0.0001) in all 3 vessels for all 36 patients with no CT evidence of CAD. Among these normal vessels, the distance gradient was not significant in the RCA for 2 patients and in the LAD in 1 patient. These were the only 3 vessels, that is, Ͻ1% among a total of 324 gradients measured in 108 vessels (36 patients multiplied by 3 vessels per patient, multiplied by 3 gradients per vessel), with a Pearson rϽ0.25, indicating a nonlinear association of HU and distance from the ostium. Table 2 considers the linear model fits in the remaining 105 vessels for the distance gradient and all 108 vessels for the other 2 models.
Regarding goodness-of-fit, the mean Pearson r values for G s and G a indicated excellent correlation, ranging from 0.79 (RCA) to 0.84 (LAD) and 0.77 (RCA) to 0.82 (LAD), respectively. The mean Pearson r values for G d were slightly lower, ranging from 0.68 in the RCA to 0.80 in the LAD. Differences in significance, P, and correlation, r, between G a and G s were very small, probably reflecting the fact that cross-sectional area and short-axis diameter are strongly related in normal coronary arteries.
Comparing the gradient between the three coronary arteries in all 36 patients (Figure 2 ), there was no significant difference for G a (ANOVA Pϭ0.503) and G s (ANOVA Pϭ0.625). However, the magnitude of G d for the RCA was significantly smaller than in the LAD and LCx (ANOVA PϽ0.001). Data over all 36 patients with no CT evidence of CAD are shown for the short-axis diameter and cross-sectional area gradients. As noted in text, 3 vessels in patients with no CT evidence of CAD had a nonlinear (rϽ0.25) relationship between mean HU and distance from the ostium (2 RCA plus 1 LAD); these 3 vessels are excluded from the distance gradient computations.
*All 22 patients with lesions yielded P values Ͻ0.0001. †All 36 patients with no CT evidence of CAD yielded P values Ͻ0.0001.
Using the maximum HU contrast opacification gradients to evaluate the potential influence of volume averaging, Ͻ5% of the 324 gradients had a Pearson rϽ0.25, as opposed to Ͻ1% for the mean HU gradient definition, reflecting the fact that the maximum is not a smooth statistic. The maximum HU gradient was highly correlated to the mean HU gradient across all patients and gradient models, indicating that volume averaging does not alter patient-specific differences in the measured gradient magnitude ( Table 3 , rϾ0.9 for 5 of 9 gradient models).
Variability and Reproducibility of Measured Gradients
HR and BMI
Gradients exhibited significant (PϽ0.05) low to moderate (Pearson rϽ0.5) correlations with HR and BMI (Table 4 ).
Over the range of standard coronary CTA patients, namely those with HR between 55 and 65 beats per minute and BMI between 20 and 30 kg/m 2 , the correlated gradient change was Ͻ1 standard deviation of the corresponding gradient observed over the 36-patient cohort with no CAD.
Drift Over Cardiac Phases
In the single patient with reconstructions at every 1% intervals in diastole, all 3 gradients exhibited strong correlation with cardiac phase in the RCA and LCx ( Table 5 ). None of Figure 2 . Mean and standard deviation of the distance (A), short-axis diameter (B), and cross-sectional area (C) gradients for the 3 major coronary arteries in 36 normal RCA, LAD, and LCx arteries, as well as corresponding gradients in 20 patients with LAD disease. Only the distance gradient has a significant difference between normal coronary arteries; the RCA is significantly closer to zero than the LAD and LCx (ANOVA PϽ0.001).
Patients with LAD stenosis have significantly different gradient magnitudes than normal patients (PϽ0.21 for all three gradient models). The regression coefficient indicates the relationship between the magnitude of the contrast opacification gradient obtained from maximum HU measurements to that obtained from mean HU measurements. The gradient change for distance is expressed as HU/cm, for diameter as HU/mm, and for area as HU/mm 2 . The gradient change reflects the expected influence on the gradient magnitude of HR (55 to 65 beats per minute) and BMI (20 to 30 kg/m 2 ) variations observed for coronary CTA patients, that is, gradient changeϭregression coefficientϫ10 ͓beats per minute or kg/m 2 ].
Table 4. Correlations and Significance Between the 3 Gradients and Each Artery With Respect to HR and BMI in 36 Patients With No CT Evidence of CAD
ϾϾ*Significant correlations (PϽ0.05).
the 3 gradients was correlated to cardiac phase in the LAD ( Table 5 ). The LAD was further evaluated throughout the entire R-R interval for the patient with retrospective ECGgated acquisition. For these reconstructions spaced by 5% of the R-R interval, none of the 3 gradients was correlated to cardiac phase in the LAD (Table 5 ). Example correlations in the RCA and LAD for G a are provided in Figure 3 . The variation of the gradient magnitude through the cardiac cycle was smaller than its variation in the 36-patient cohort with no CAD (Figure 4) . Gradients in the LCx demonstrated the largest variation with respect to cardiac phase.
Interobserver Agreement
Interobserver agreement was excellent for all gradients and arteries ( Table 6 ). In addition to high agreement, the variation in gradient magnitudes observed between readers ( Table 6 ) was significantly smaller than both the entire sample of arteries as well as the observed cardiac phases in 1 patient (Figure 4 ).
Preliminary Evaluation of Gradients in Patients With CAD
All 3 gradients in all 22 patients with the LAD lesions were significantly different from zero (Pϭ0.0001, Figure 1 ). Regarding goodness-of-fit, the mean Pearson r values for G s and G a indicated strong correlation; for G d there was excellent correlation ( Table 2 ). The slightly lower Pearson r values for G s and G a probably reflect the more challenging segmentation and subsequent imprecision in the short-axis diameter and area measurements for vessels with lesions.
All 3 gradients in patients with LAD stenosis Ն50% had mean values significantly different (PϽ0.021) compared with the corresponding gradients in patients with no CT evidence of CAD (Figure 1) . The difference was most consistent for the short-axis diameter gradient ( Figure 2B ).
Phantom Experiment to Determine Potential HU Changes Over the Coronary Artery Field of View
The mean (range) HU measurements in the Delrin cylinder were 329.6 HU (327.8 to 332.3 HU). The very small gradient over the 4.5 HU range had a slope of 0.0225 HU/cm, with the HU decreasing as measurements approached the tube anode as determined by the orientation of the phantom within the scanner.
Discussion
Wide area detector CT enables noninvasive quantitative assessment of coronary contrast changes with temporal uniformity. The current data confirm that opacification gradients exist in patients with normal coronary arteries. Customized image segmentation software is required to quantify attenuation differences over short coronary distances.
Until recently, coronary CTA was performed with retrospective ECG gating so that cardiac function could be estimated in conjunction with CAD. Because of the lower radiation dose, prospective ECG gating is used with increasing frequency 8 ; with this acquisition protocol, data regarding cardiac function is not available. State-of-the-art multidetector CT technology is now moving closer to acquiring information regarding myocardial perfusion. However, perfusion data require specialized protocols, ideally performed at both rest and stress. Unlike the assessment of wall motion or perfusion, coronary contrast opacification gradients are simple parameters that only require postprocessing tools.
We defined, computed, and analyzed 3 coronary contrast opacification gradients to quantify mean HU changes in normal coronary arteries. The distance gradient G d is the linear fit that most resembles earlier work that quantifies the decrease in HU between 2 points in a coronary artery. 6 When compared with the cross-sectional area and short-axis diameter gradients, the distance gradients may be considered easier to interpret but in a small number of cases demonstrate nonlinearities that may limit potential clinical use. One possible reason for the slightly lower goodness-of-fit for G d compared with G s and G a is the presence of branching vessels. Those linear fits inherently measure changes in HU with respect to coronary lumen size and thus are expected to be less sensitive to highly variable coronary branching patterns, a potential cause of nonlinearity in G d . Considering only significance and correlation, the short-axis diameter gradient slightly outperformed the cross-sectional area gradient. Neither of those gradients demonstrated a significant difference between the 3 major coronary arteries. However, the distance gradient was significantly different in the RCA than in the left coronary system.
In vessels with no wall calcification, gradients computed using maximum HU values are insensitive to partial volume averaging because the voxel with maximum HU for every cross section is expected to contain only contrast-enhanced blood. In the 108 normal vessels, the maximum HU gradients had excellent correlation with the mean HU gradients. Although small wall calcium (below visual threshold for detection) could not be definitively excluded, the excellent corre-lation for all vessels argues that partial volume effects and imperfect segmentation do not skew gradient magnitude differences between patients.
The potential utility of gradients in coronary CTA will depend on the ease and reproducibility of the measurements as well as separation between vessels with and without CAD. Regarding gradient measurements, the required customized software can be used on current DICOM coronary CTA data. Regarding reproducibility, for the patients with no CAD, we observed limited impact of varying HR, BMI, cardiac phases, and different cardiovascular readers in comparison to variations in the patient population. In fact, many correlations such as those for HR and BMI were no more than moderate and may be irrelevant in larger populations. Regardless, the ensemble of results well characterizes the distribution of all gradients in patients with no CAD, the primary purpose of the study.
Our understanding of gradients in diseased vessels is very sparse. However, the preliminary evaluation in 22 patients with LAD disease suggests a consistent difference with normal patients. Additional studies will be required to confirm the differences between patients with and without CAD for different lesion types. Initial studies will focus on patients with both focal lesions and diffuse CAD, as the latter group is expected to have differences over long segments of the coronary arteries and have a graded, continuous pressure decrease along the length of the artery. 9 Normal coronary arteries do not have a measurable drop in pressure along their course. However, the reproducibility of the gradient data argues that differences in opacification are linked to flow. Regarding coronary lesions, the most important factor to determine resistance is the minimum crosssectional area, 10 incorporated into the definition of G a .
If 1 or more gradients can be reliably measured across lesions or in patients with diffuse CAD, and if those gradients differ from the normal coronary gradients established in this work, these parameters could potentially be incorporated into the evaluation of CAD. It is important to acknowledge that the confirmation of clinical utility will ultimately require measures of clinical outcome from multiple centers, and thus the study of contrast opacification gradients is only in its infancy. However, the low level of HU drift for the scanner and the ease in computing the gradients makes it amenable for future work. . Standard deviations of the magnitude for all 3 gradients for the 36 patients with no CT evidence of CAD (blue bars), 60% to 85% cardiac phase in 1 patient (red bars), 5% to 95% cardiac phase at 5% intervals in a single LAD in 1 patient (purple bars), and between cardiovascular imagers performing the segmentation for 9 cardiac phases in 1 patient (green bars). 
Limitations
All patients received sublingual nitroglycerin for coronary vasodilation, increasing coronary blood flow. It is not possible to determine the influence on the calculated gradients, but the point could be relatively moot because essentially all coronary CTA is performed after nitroglycerin administration. All patients had identical iodinated contrast injection and bolus tracking protocols. However, the influence of contrast media volume, rate of injection, and iodine concentration will also require further evaluation. All patients were evaluated on a single CT platform that offers temporal uniformity; that is, data from the entire coronary tree was acquired at a single phase of opacification. Future work will evaluate if and how the gradients change when the image data are acquired on different CT platforms. Another limitation is that there is no coronary catheterization confirmation that the patients presumed to have no CAD are in fact normal. This evaluation was performed retrospectively, and because of the high negative predictive value of CT, patients with a normal study typically require no additional imaging. Future work using patients with and without CAD will confirm the presence of opacification gradients in patients with no CAD confirmed with coronary catheterization. Finally, refinements in the postprocessing software will advance our ability to rapidly determine the gradients with little user input. The present software requires manual correction near branch vessels. The time for a complex coronary system (all vessels) is 45 minutes (standard deviation 10 minutes). Further refinements to the software are expected to reduce the time burden to levels compatible with clinical workflow.
Conclusion
The mean HU changes along the course of a coronary artery are termed contrast opacification gradients and can be reproducibly evaluated with a 320-detector row CT acquisition. In normal coronary arteries, the gradients computed with respect to cross-sectional lumen short-axis diameter and area orthogonal to the coronary centerline are significant, linear, and not significantly influenced by the coronary artery (LAD versus LCx versus RCA). The moderate influence from BMI, HR, and cardiac phase variations are probably compatible with changes in motion artifact and signal-to-noise ratio currently observed in clinical coronary CTA. Studying changes be-tween coronary arteries in the same patient and changes within individual coronary arteries may provide insight with respect to coronary physiology not previously accessible noninvasively. Early experience in vessels with lesions demonstrates feasibility and further studies are warranted. The clinical utility of these measurements will rely on potential differences when these new parameters are studied in patients with CAD.
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